基因检测公司GeneDx Holdings（股票代码：WGS）今日盘中股价大跌33.68%，尽管公司最新公布的季度业绩超出市场预期。这一异常走势引发了投资者的广泛关注。
根据GeneDx Holdings发布的截至3月31日的季度财报显示，公司调整后每股收益为0.27美元，远高于分析师预期的0.06美元，同时营收同比增长40.3%至8576万美元，同样超过了分析师预期的7947万美元。然而，尽管业绩表现亮眼，公司股价却出现大幅下跌。
造成股价下跌的原因可能有以下几点：首先，尽管调整后业绩表现良好，但公司实际报告的每股亏损为0.23美元，当季净亏损653万美元，表明公司仍未实现盈利。其次，过去三个月内，分析师对公司的平均盈利预期下调了约11.5%，这可能引发了投资者对公司未来增长前景的担忧。最后，考虑到GeneDx Holdings的股价在本季度已经上涨了32.1%，今年迄今为止更是上涨了52.2%，投资者可能认为当前股价已经充分反映了公司的业绩预期，因此选择获利了结。这种情况下，即使公司发布超预期的业绩，也可能引发股价回调。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.